Prosthesis Dislocation After Transapical Valve-In-Valve Mitral Valve Implantation

Can J Cardiol. 2016 Dec;32(12):1576.e7-1576.e9. doi: 10.1016/j.cjca.2016.03.006. Epub 2016 Mar 19.

Abstract

Transapical valve-in-valve mitral valve implantation (TA-MVI) has been described as an alternative treatment option in patients with degenerated bioprostheses in the mitral position. We report the first case of prosthesis dislocation and migration into the left atrium after TA-MVI. A new prosthesis was implanted using the same approach. The dislocated prosthesis was successfully removed through the left atrial appendage through an extended anterolateral thoracotomy without the use of cardiopulmonary bypass.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Bioprosthesis / adverse effects*
  • Cardiac Catheterization / methods*
  • Echocardiography, Transesophageal / methods
  • Female
  • Heart Valve Prosthesis Implantation* / adverse effects
  • Heart Valve Prosthesis Implantation* / methods
  • Humans
  • Mitral Valve* / diagnostic imaging
  • Mitral Valve* / pathology
  • Mitral Valve* / surgery
  • Prosthesis Design
  • Prosthesis Failure*
  • Reoperation / methods
  • Thoracotomy / methods
  • Treatment Outcome